Dean Investment Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $271K | Sell |
700
-6
| -0.8% | -$2.23K | 0.04% | 191 |
|
|
2026
Q1 | $207K | Sell |
706
-10
| -1% | -$3.29K | 0.03% | 190 |
|
|
2025
Q4 | $251K | Sell |
716
-23
| -3% | -$7.77K | 0.04% | 196 |
|
|
2025
Q3 | $239K | Sell |
739
-17
| -2% | -$5.29K | 0.03% | 201 |
|
|
2025
Q2 | $294K | Buy |
756
+125
| +20% | +$50.3K | 0.04% | 201 |
|
|
2025
Q1 | $274K | Buy |
631
+37
| +6% | +$14.9K | 0.04% | 208 |
|
|
2024
Q4 | $219K | Sell |
594
-67
| -10% | -$28K | 0.03% | 214 |
|
|
2024
Q3 | $344K | Buy |
661
+21
| +3% | +$11.2K | 0.05% | 209 |
|
|
2024
Q2 | $347K | Sell |
640
-369
| -37% | -$195K | 0.05% | 206 |
|
|
2024
Q1 | $523K | Sell |
1,009
-111
| -10% | -$55.2K | 0.07% | 194 |
|
|
2023
Q4 | $528K | Sell |
1,120
-40
| -3% | -$18.5K | 0.08% | 189 |
|
|
2023
Q3 | $505K | Sell |
1,160
-16
| -1% | -$7.26K | 0.08% | 188 |
|
|
2023
Q2 | $522K | Sell |
1,176
-60
| -5% | -$27.7K | 0.09% | 198 |
|
|
2023
Q1 | $568K | Sell |
1,236
-137
| -10% | -$65.2K | 0.09% | 193 |
|
|
2022
Q4 | $704K | Sell |
1,373
-17
| -1% | -$8.63K | 0.12% | 195 |
|
|
2022
Q3 | $631K | Sell |
1,390
-38
| -3% | -$18.2K | 0.13% | 199 |
|
|
2022
Q2 | $689K | Sell |
1,428
-51
| -3% | -$25.2K | 0.13% | 206 |
|
|
2022
Q1 | $727K | Sell |
1,479
-134
| -8% | -$61.3K | 0.13% | 205 |
|
|
2021
Q4 | $748K | Sell |
1,613
-40
| -2% | -$16.8K | 0.13% | 211 |
|
|
2021
Q3 | $616K | Sell |
1,653
-10
| -0.6% | -$3.8K | 0.12% | 219 |
|
|
2021
Q2 | $635K | Sell |
1,663
-9
| -0.5% | -$3.44K | 0.12% | 219 |
|
|
2021
Q1 | $600K | Buy |
1,672
+1
| +0.1% | +$322 | 0.11% | 216 |
|
|
2020
Q4 | $537K | Sell |
1,671
-55
| -3% | -$16.9K | 0.11% | 220 |
|
|
2020
Q3 | $464K | Sell |
1,726
-30
| -2% | -$8.07K | 0.11% | 210 |
|
|
2020
Q2 | $462K | Sell |
1,756
-7
| -0.4% | -$1.87K | 0.11% | 205 |
|
|
2020
Q1 | $400K | Buy |
1,763
+677
| +62% | +$184K | 0.09% | 213 |
|
|
2019
Q4 | $328K | Sell |
1,086
-124
| -10% | -$34.1K | 0.05% | 210 |
|
|
2019
Q3 | $291K | Sell |
1,210
-11
| -0.9% | -$3.01K | 0.04% | 206 |
|
|
2019
Q2 | $345K | Sell |
1,221
-5
| -0.4% | -$1.37K | 0.05% | 204 |
|
|
2019
Q1 | $352K | Sell |
1,226
-1,022
| -45% | -$296K | 0.05% | 204 |
|
|
2018
Q4 | $590K | Sell |
2,248
-181
| -7% | -$49.8K | 0.09% | 194 |
|
|
2018
Q3 | $666K | Sell |
2,429
-82
| -3% | -$21.3K | 0.09% | 201 |
|
|
2018
Q2 | $598K | Sell |
2,511
-61
| -2% | -$14.1K | 0.09% | 199 |
|
|
2018
Q1 | $565K | Sell |
2,572
-2,722
| -51% | -$639K | 0.08% | 198 |
|
|
2017
Q4 | $1.19M | Sell |
5,294
-84
| -2% | -$17.9K | 0.18% | 145 |
|
|
2017
Q3 | $1.02M | Sell |
5,378
-121
| -2% | -$23K | 0.16% | 140 |
|
|
2017
Q2 | $1.03M | Sell |
5,499
-232
| -4% | -$41.7K | 0.16% | 138 |
|
|
2017
Q1 | $948K | Sell |
5,731
-58
| -1% | -$9.23K | 0.16% | 132 |
|
|
2016
Q4 | $832K | Buy |
5,789
+2,373
| +69% | +$318K | 0.14% | 140 |
|
|
2016
Q3 | $428K | Sell |
3,416
-32
| -0.9% | -$4.13K | 0.08% | 194 |
|
|
2016
Q2 | $453K | Sell |
3,448
-62
| -2% | -$8.48K | 0.09% | 184 |
|
|
2016
Q1 | $488K | Sell |
3,510
-56
| -2% | -$7.48K | 0.1% | 177 |
|
|
2015
Q4 | $497K | Sell |
3,566
-389
| -10% | -$53.6K | 0.11% | 165 |
|
|
2015
Q3 | $554K | Sell |
3,955
-215
| -5% | -$32.3K | 0.12% | 158 |
|
|
2015
Q2 | $684K | Sell |
4,170
-40
| -1% | -$6.39K | 0.16% | 157 |
|
|
2015
Q1 | $650K | Sell |
4,210
-6,057
| -59% | -$862K | 0.15% | 159 |
|
|
2014
Q4 | $1.29M | Sell |
10,267
-267
| -3% | -$33K | 0.3% | 116 |
|
|
2014
Q3 | $1.26M | Sell |
10,534
-172
| -2% | -$19.7K | 0.31% | 99 |
|
|
2014
Q2 | $1.15M | Sell |
10,706
-433
| -4% | -$44.6K | 0.27% | 112 |
|
|
2014
Q1 | $1.11M | Sell |
11,139
-651
| -6% | -$58.9K | 0.27% | 113 |
|
|
2013
Q4 | $1.09M | Sell |
11,790
-772
| -6% | -$68.6K | 0.26% | 121 |
|
|
2013
Q3 | $1.05M | Sell |
12,562
-222
| -2% | -$19K | 0.27% | 120 |
|
|
2013
Q2 | $1.05M | Buy |
+12,784
| New | +$957K | 0.3% | 105 |
|
Other funds holding ELV
Dean Investment Associates's ELV Position: Q2 2026 in Review
Dean Investment Associates reduced its Elevance Health (ELV) stake by 0.85% in Q2 2026, selling an estimated $2.23K and leaving 700 shares worth $271K. The position accounts for 0.04% of the portfolio, ranked #191.
Dean Investment Associates first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.29M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Dean Investment Associates held 700 shares of Elevance Health worth $271K as of Q2 2026.
- Dean Investment Associates sold 6 Elevance Health shares in Q2 2026, an estimated $2.23K.
- Elevance Health made up 0.04% of Dean Investment Associates's portfolio in Q2 2026, its #191 holding.
- Dean Investment Associates first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Dean Investment Associates's Elevance Health position peaked at $1.29M in Q4 2014.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Dean Investment Associates's 13F filing for Q2 2026, filed 14 Aug 2026.